Category: Drug Discovery
Drug Discovery market research reports by GlobalData
-
MELAS Syndrome: Competitive Landscape
MELAS Syndrome: Competitive Landscape MELAS Syndrome: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in MELAS therapeutics. More than 20,000 diagnosed prevalent cases of MELAS Syndrome are anticipated in 2024 in the 16 count ... Read More
-
Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update
Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan and Canada) and provides an Excel-based forecast model for the Amyotrophic Lateral Sclerosis (ALS) market through 2029. The prevalenc ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Attention Deficit Hyperactivity Disorder (ADHD) market through 2032. The ... Read More
-
Thematic Intelligence: Rare Disease
Thematic Intelligence: Rare Disease Summary In recent years, there has been growing recognition of the importance of rare diseases as a global health priority, leading to increased research efforts, policy initiatives, and collaborative partnerships aimed at accelerating progress in this field. Key ... Read More
-
Post-operative Pain (POP) - Competitive Landscape
Post-operative Pain (POP) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in POP therapeutics. In 2024, more than 34,000,000 incident cases of POP are anticipated in the 16 countries covered in GlobalData’s epidemiology for ... Read More
-
Friedreich Ataxia (FRDA) - Competitive Landscape
Friedreich Ataxia (FRDA) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in FRDA therapeutics. More than 54,000 diagnosed prevalent cases of FRDA are anticipated in 2024 in the 16 countries covered in GlobalData’s epidemiol ... Read More
-
New Prescription - Generative AI meets Healthcare (Vol. 2)
New Prescription - Generative AI meets Healthcare (Vol. 2) Summary GlobalData's latest Innovation Radar report New Prescription: Generative AI Meets Healthcare (Vol. 2), expands upon its predecessor and digs further into the transformative capabilities of generative AI within the pharmaceutical and ... Read More
-
Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs
Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs Summary This comprehensive conversation analysis report delves into the most popular weight loss drugs on Reddit in the last six months (October 1st, 2023, to March 31st, 2024), offering a nuanced understanding of their prominence and po ... Read More
-
Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033
Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033 Summary Methicillin-resistant Staphylococcus aureus (MRSA) is a virulent, antibiotic-resistant bacteria that is associated with considerable morbidity and mortality (Vázquez-Sánchez et al., 2022). MRSA can ... Read More
-
New Drug Approvals and Their Contract Manufacture - 2024 Edition
New Drug Approvals and Their Contract Manufacture - 2024 Edition Summary This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called CMO Sco ... Read More
-
Acne Vulgaris (AV) - Competitive Landscape
Acne Vulgaris (AV) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AV therapeutics. GlobalData epidemiologists estimated more than 403 million diagnosed prevalent cases of AV in 2023 in the 16 countries covered in Global ... Read More
-
Resistant Hypertension (RH) - Competitive Landscape
Resistant Hypertension (RH) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in RH therapeutics. GlobalData epidemiologists estimated more than 79 million diagnosed prevalent cases of RH in 2023 in the 16 countries covered i ... Read More
-
Psychedelics Therapeutics Development and Trends, 2024
Psychedelics Therapeutics Development and Trends, 2024 Summary This report provides a summary of the current and future state of the psychedelic therapeutic sector, offering a high-level analysis of key trends and developments within the industry, including regulatory, clinical, and market dynamics. ... Read More
-
Retinitis Pigmentosa (RP) - Competitive Landscape
Retinitis Pigmentosa (RP) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in RP therapeutics. More than 1,000,000 diagnosed prevalent cases of RP are expected in 2024 in the 16 countries covered in GlobalData’s epidemiology ... Read More
-
Peripheral Artery Disease (PAD): Competitive Landscape
Peripheral Artery Disease (PAD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PAD therapeutics. More than 18,000,000 diagnosed prevalent cases of PAD are expected in 2024 in the 16 countries covered in GlobalData’s epid ... Read More
-
Fuchs Endothelial Corneal Dystrophy (FECD): Competitive Landscape
Fuchs Endothelial Corneal Dystrophy (FECD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in FECD therapeutics. More than 133,000,000 total prevalent cases of FECD are expected in 2024 in the 16 countries covered in GlobalD ... Read More
-
Augmented Reality in Healthcare - Thematic Research
Augmented Reality in Healthcare - Thematic Research Summary Augmented reality (AR) is a technology that allows the user to see the real world overlaid with digital data. According to GlobalData forecasts, the AR market will be worth $100 billion by 2030, up from $22 billion in 2022. Rather than enab ... Read More
-
Rare Disease Pipeline Analysis Landscape in 2023
Rare Disease Pipeline Analysis Landscape in 2023 Summary This report investigates the Rare Disease Pipeline Analysis Landscape in 2023 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via reg ... Read More
-
Premature Labor (PL) -Competitive Landscape
Premature Labor (PL) -Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PL therapeutics. More than 5,000,000 total prevalent cases of PL are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology foreca ... Read More
-
Hyperinsulinemia (HI) - Competitive Landscape
Hyperinsulinemia (HI) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HI therapeutics. More than 1.07 billion prevalent cases of HI are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecas ... Read More
-
Acute Ischemic Stroke (AIS) - Competitive Landscape
Acute Ischemic Stroke (AIS) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AIS therapeutics. More than 90,000,000 diagnosed prevalent cases of AIS are anticipated in 2023 in the 16 countries covered in GlobalData’s epid ... Read More
-
Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countri ... Read More
-
Heart Failure in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Heart Failure in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Heart Failure (HF) market through 2032. Gl ... Read More
-
Dravet Syndrome (DS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Dravet Syndrome (DS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in DS therapeutics. More than 123,000 diagnosed prevalent cases of DS are anticipated in 2023 in ... Read More
-
Crohn's Disease in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Crohn's Disease in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032 Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan, Canada) and provides an Excel-based forecast model for Crohn's Disease market through 2032. ... Read More
Research Assistance
